Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury Jul 20, 2022 | 2018, Archives of Toxicology, Publication - legacy work ‹ Previous Predicting drug-induced cholestasis: preclinical models Next › New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease
